• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, August 25, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

NFCR fellow Susan Band Horwitz named giant of cancer care

Bioengineer by Bioengineer
June 3, 2019
in Biology
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Becomes the fifth national foundation for cancer research scientist to receive the honor

IMAGE

Credit: Albert Einstein College of Medicine and OncLive®

ROCKVILLE, MD – National Foundation for Cancer Research (NFCR) Fellow Susan Band Horwitz, Ph.D., was recognized last Thursday evening as a Giant of Cancer Care in an event at the Adler Planetarium in Chicago. She was accompanied by 14 other highly respected healthcare professionals who are advancing the field of oncology by their contributions in research and clinical practice in receiving the honor.

Doctor Horwitz joins four other current and former NFCR-funded scientists–the late Waun Ki Hong, M.D., F.A.C.P., D.M.Sc. (Hon.) (inducted in 2018), W.K. Alfred Yung, M.D. (2018), Robert Bast, M.D. (2015), and Daniel Von Hoff, M.D. (2016)–as Giants of Cancer Care. Other oncology research luminaries, including James Allison, Ph.D. (2014), winner of NFCR’s 2014 Szent-Györgyi Prize for Progress in Cancer Research, too are members of this exclusive club, comprised of fewer than 100 of the world’s cancer-battling elite.

“Congratulations to Susan for this wonderful recognition,” states NFCR President and CEO Sujuan Ba, Ph.D. “The National Foundation for Cancer Research is proud of you and your vast contributions to cancer drug development and overcoming drug resistance. Our organization is honored to have been supporting your work for the past two decades.”

A distinguished professor and Rose C. Falkenstein Chair in Cancer Research at the Albert Einstein College of Medicine in New York, Dr. Horwitz elucidated the mechanism of action of Taxol®, a natural product obtained from the yew tree. Specifically, she discovered and proved that the molecule, whose chemical name is paclitaxel, binds to microtubules in cells, stabilizing them, thereby leading to cell cycle arrest and subsequent tumor cell death. This body of work enabled the successful translation of the drug into the clinic, and it is now one of the most frequently prescribed medications in the world for the treatment of ovarian, breast and lung cancers.

Dr. Horwitz’s current NFCR-funded work includes research into which tubulin proteins in the microtubules may have a role in resistance to Taxol, as well as efforts that may help predict which patients would be more likely to respond well to the treatment. Also, in collaboration with another NFCR fellow, the University of Pennsylvania’s Amos B. Smith III, Ph.D., she is developing analogues of another natural product, discodermolide, a microtubule stabilizing agent which exhibits low toxicity. These may in the future serve as additional cancer treatments.

###

Presented since 2013 by OncLive®, a respected cancer communications website, Giants of Cancer Care awards celebrate the achievements of leading researchers and educators whose discoveries have helped propel the field of oncology forward and established the building blocks for future advances. In 2019, a selection committee of over 100 eminent oncologists, researchers and clinicians chose honorees from several different tumor type and specialty categories.

About the National Foundation for Cancer Research

The National Foundation for Cancer Research (NFCR) is a 501(c)(3) non-profit organization that provides scientists in the lab the funding they need to make and apply game-changing discoveries in cancer treatments, detection, prevention and, ultimately, a cure. It has distinguished itself in the cancer sector by emphasizing long-term, transformative research often overlooked by other major funding sources. With the help of more than 5.3 million individual donors over the last 46 years, NFCR has delivered more than $380 million in funding to public education and cancer research leading to several important, life-saving discoveries. For more information, visit http://www.nfcr.org.

A high-resolution version of the included image is available upon request (sources: Albert Einstein College of Medicine and OncLive®).

Media Contact
Bradley Gillenwater
[email protected]

Tags: BiotechnologycancerCell BiologyHealth CareMedicine/HealthMicrobiologyMolecular Biology
Share12Tweet8Share2ShareShareShare2

Related Posts

The Active Role of Repetitive DNA in the Human Brain Uncovered

The Active Role of Repetitive DNA in the Human Brain Uncovered

August 25, 2025
Durable and Efficient H2 Evolution Achieved with Strongly Coupled Pt–N-Mo Cluster Heterostructure in Anion-Exchange Membrane Electrolyzers

Durable and Efficient H2 Evolution Achieved with Strongly Coupled Pt–N-Mo Cluster Heterostructure in Anion-Exchange Membrane Electrolyzers

August 25, 2025

Sugars Signal Guard Cell Ion Transport in Red Light

August 25, 2025

Innovative 3D-Printed Scaffolds Pave the Way for Spinal Cord Injury Recovery

August 25, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    143 shares
    Share 57 Tweet 36
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    142 shares
    Share 57 Tweet 36
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    115 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    81 shares
    Share 32 Tweet 20

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Revolutionary Cyclic Thioether Additive Boosts Lithium Metal Batteries to 3,000 Stable Cycles!

Breakthroughs in Screening Techniques and Point-of-Care Diagnostics Transform Colorectal Cancer Detection

Introducing the Second Beijing Consensus on Holistic Integrative Medicine for Managing Helicobacter pylori-Associated Disease-Syndrome

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.